newsfilter
← Latest News
PR Newswire·

Proteostasis Therapeutics Regains Compliance with Nasdaq Listing Standards

Proteostasis Therapeutics, Inc. (Nasdaq:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking ...